Thomas E. Hutson, D.O., Pharm.D., Ph.D., chief of the Hematology Oncology Division in the Department of Internal Medicine at Texas Tech University Health Sciences Center (TTUHSC) and director of the ...

Dr. Catherine Wu discussed the unique aspects of clear cell renal cell carcinoma and the challenges of targeting it with a ...

Groundbreaking findings from the landmark CLEAR (Clinical trial Comparing Lenvatinib with Ecerolimus or Pembrolizumab in ...

(UroToday.com) The 2025 American Society of Clinical Oncology (ASCO) Genitourinary (GU) Annual Symposium held in San ...

There are currently 82,000 incident cases of RCC annually in the United States (account for 3–5% of cancers), with 15,000 deaths annually in the United States. The overall 5-year mortality risk is ~30 ...

The following is a summary of “Risk factors for renal insufficiency and survival implications after radical nephrectomy and ...

Patients with metastatic renal cell carcinoma staged pT1-4 Nx M1 were ... All patients had tumor nephrectomy or metastatic surgery at the University of Göttingen, Urology Department or at an ...

Nephron-sparing surgery (NSS) for renal cell carcinoma has the advantage of ... into the inferior vena cava or renal vein, partial nephrectomy is not recommended Kidney damage due to warm ischemia ...

Clear cell renal cell carcinoma (ccRCC) is the most prevalent and lethal subtype ... the patient underwent cytoreductive nephrectomy (CN), metastasectomy, and targeted therapy. According to the ...

McDermott first revealed in 2021 that he had squamous cell carcinoma "several times." He added that he also has had basal cell cancer. According to the American Cancer Society, basal cell and ...

Background Laparoscopic radical nephrectomy (LRN) is the actual gold-standard for the treatment of clinically localized renal cell carcinoma (RCC) (cT1–2 with no indications for nephron-sparing ...